Dr. Fine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-692-9600Fax+1 901-692-9606
Summary
- Dr. Richard Fine is a general surgeon in Germantown, TN and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital for Women, Methodist Le Bonheur Germantown Hospital, Methodist Healthcare Memphis Hospitals, and Baptist Memorial Hospital - Memphis. He received his medical degree from Medical College of Georgia School of Medicine and has been in practice 34 years. He specializes in breast and is experienced in breast cancer, breast pain, sentinel node localization, core needle biopsy, and breast reconstruction.
Education & Training
- Rush University Medical CenterResidency, Surgery, 1983 - 1988
- Medical College of Georgia at Augusta UniversityClass of 1983
Certifications & Licensure
- TN State Medical License 2012 - 2026
- GA State Medical License 1988 - 2025
- IL State Medical License 1983 - 1990
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Memphis Magazine: Top Doctors Castle Connolly, 2014
- Fellow American College of Surgeons
Clinical Trials
- PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Mastectomy Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 2 citationsCryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.Richard E Fine, Richard C Gilmore, Kenneth R Tomkovich, Jill R Dietz, Michael P Berry
Annals of Surgical Oncology. 2024-10-01 - Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 ...Richard C Gilmore, Richard E Fine
Annals of Surgical Oncology. 2024-08-01 - 55 citationsCryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 TrialRichard E. Fine, Richard C. Gilmore, Jill R. Dietz, Susan K. Boolbol, Michael P Berry
Annals of Surgical Oncology. 2021-08-15
Press Mentions
- FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to SurgeryNovember 8th, 2024
- IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24th, 2024
- Tumor Cryoablation Treatment Proven in Breast Cancer StudyOctober 14th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: